Loading…

Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation

Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation...

Full description

Saved in:
Bibliographic Details
Published in:Life sciences (1973) 2017-12, Vol.190, p.103-109
Main Authors: Kawada, Toru, Shimizu, Shuji, Yamamoto, Hiromi, Miyamoto, Tadayoshi, Shishido, Toshiaki, Sugimachi, Masaru
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3
cites cdi_FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3
container_end_page 109
container_issue
container_start_page 103
container_title Life sciences (1973)
container_volume 190
creator Kawada, Toru
Shimizu, Shuji
Yamamoto, Hiromi
Miyamoto, Tadayoshi
Shishido, Toshiaki
Sugimachi, Masaru
description Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation separately from its central effect. In eight anesthetized Wistar rats, changes in efferent sympathetic nerve activity (SNA) and AP in response to a carotid sinus pressure input were compared before and during an intravenous administration of moxonidine (100μgkg−1 bolus followed by a continuous infusion at 200μg·kg−1·h−1). Moxonidine significantly narrowed the range of the AP response (55.3±5.8 to 39.1±6.1mmHg, P
doi_str_mv 10.1016/j.lfs.2017.09.038
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1945719129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320517304885</els_id><sourcerecordid>1945719129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3</originalsourceid><addsrcrecordid>eNp9kc-OFCEQxonRuOPqA3gxJF689AjdDQ3xZDbrn2QTPeiZ0FDtMumGFujJ7jv40NZkVg8ePJHi-9UHVR8hLznbc8bl28N-nsq-ZXzYM71nnXpEdlwNumGy44_JjrG2b7qWiQvyrJQDY0yIoXtKLlqlZa-42JFfXyGH9RaynekRctkKdRDrqYRpAldpmmg4XRwhJlSXdJdi8CECTZFmW6mzOdXgaQkR9RGrDNMMd80CPtgKqNwvq623UIOjNld8Ee3XDKVsGWiGH9tsa0jxOXky2bnAi4fzknz_cP3t6lNz8-Xj56v3N43r-6E2ox4cE62H3otx8D1IPUjLxMRG3_LODlIrrhV4xzrJnNUdFyO3AALU0DnfXZI3Z981p58blGqWUBzMs42AMxquezFwzVuN6Ot_0EPacsTfISWlElJxhRQ_Uy6nUnB8s-aw2HxvODOnqMzBYFTmFJVh2mBU2PPqwXkbcVN_O_5kg8C7MwC4imOAbIoLEB1uNWMwxqfwH_vfwoCoGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1966856818</pqid></control><display><type>article</type><title>Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation</title><source>ScienceDirect Journals</source><creator>Kawada, Toru ; Shimizu, Shuji ; Yamamoto, Hiromi ; Miyamoto, Tadayoshi ; Shishido, Toshiaki ; Sugimachi, Masaru</creator><creatorcontrib>Kawada, Toru ; Shimizu, Shuji ; Yamamoto, Hiromi ; Miyamoto, Tadayoshi ; Shishido, Toshiaki ; Sugimachi, Masaru</creatorcontrib><description>Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation separately from its central effect. In eight anesthetized Wistar rats, changes in efferent sympathetic nerve activity (SNA) and AP in response to a carotid sinus pressure input were compared before and during an intravenous administration of moxonidine (100μgkg−1 bolus followed by a continuous infusion at 200μg·kg−1·h−1). Moxonidine significantly narrowed the range of the AP response (55.3±5.8 to 39.1±6.1mmHg, P&lt;0.05) without changing the minimum AP (77.2±6.4 to 80.7±5.1mmHg, not significant). In the neural arc, moxonidine reduced the minimum SNA (56.6±5.9 to 29.7±6.2%, P&lt;0.05) without affecting the range of the SNA response (45.3±5.5 to 40.2±5.0%, not significant). In the peripheral arc, moxonidine increased the intercept (3.0±8.5 to 51.1±7.2mmHg, P&lt;0.01) and reduced the slope (1.28±0.06 to 0.92±0.15mmHg/%, P&lt;0.05). Moxonidine increased AP at any given SNA, suggesting that the peripheral vasoconstrictive effect is stronger than generally recognized. The peripheral vasoconstrictive effect of moxonidine may partly offset the vasodilatory effect attained by centrally-mediated sympathoinhibition. [Display omitted]</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2017.09.038</identifier><identifier>PMID: 28964815</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adrenergic receptors ; Animals ; Antihypertensive Agents - pharmacology ; Antihypertensives ; Arterial Pressure - drug effects ; Baroreceptors ; Baroreflex - drug effects ; Blood pressure ; Carotid sinus ; Carotid Sinus - drug effects ; Carotid Sinus - metabolism ; Carotid sinus baroreflex ; Clinical trials ; Drug delivery systems ; Drugs ; Imidazoles - administration &amp; dosage ; Imidazoles - pharmacology ; Imidazoline ; Imidazoline agonist ; Imidazoline receptors ; Infusions, Intravenous ; Injections, Intravenous ; Intravenous administration ; Male ; Mercury ; Moxonidine ; Open-loop systems analysis ; Rats ; Rats, Wistar ; Receptors ; Receptors (physiology) ; Reflexes ; Rodents ; Selectivity ; Sinus ; Sympathetic nerve activity ; Sympathetic Nervous System - drug effects ; Sympathetic Nervous System - metabolism ; Vasoconstriction - drug effects</subject><ispartof>Life sciences (1973), 2017-12, Vol.190, p.103-109</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier BV Dec 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3</citedby><cites>FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3</cites><orcidid>0000-0002-4429-1802</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28964815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawada, Toru</creatorcontrib><creatorcontrib>Shimizu, Shuji</creatorcontrib><creatorcontrib>Yamamoto, Hiromi</creatorcontrib><creatorcontrib>Miyamoto, Tadayoshi</creatorcontrib><creatorcontrib>Shishido, Toshiaki</creatorcontrib><creatorcontrib>Sugimachi, Masaru</creatorcontrib><title>Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation separately from its central effect. In eight anesthetized Wistar rats, changes in efferent sympathetic nerve activity (SNA) and AP in response to a carotid sinus pressure input were compared before and during an intravenous administration of moxonidine (100μgkg−1 bolus followed by a continuous infusion at 200μg·kg−1·h−1). Moxonidine significantly narrowed the range of the AP response (55.3±5.8 to 39.1±6.1mmHg, P&lt;0.05) without changing the minimum AP (77.2±6.4 to 80.7±5.1mmHg, not significant). In the neural arc, moxonidine reduced the minimum SNA (56.6±5.9 to 29.7±6.2%, P&lt;0.05) without affecting the range of the SNA response (45.3±5.5 to 40.2±5.0%, not significant). In the peripheral arc, moxonidine increased the intercept (3.0±8.5 to 51.1±7.2mmHg, P&lt;0.01) and reduced the slope (1.28±0.06 to 0.92±0.15mmHg/%, P&lt;0.05). Moxonidine increased AP at any given SNA, suggesting that the peripheral vasoconstrictive effect is stronger than generally recognized. The peripheral vasoconstrictive effect of moxonidine may partly offset the vasodilatory effect attained by centrally-mediated sympathoinhibition. [Display omitted]</description><subject>Adrenergic receptors</subject><subject>Animals</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Antihypertensives</subject><subject>Arterial Pressure - drug effects</subject><subject>Baroreceptors</subject><subject>Baroreflex - drug effects</subject><subject>Blood pressure</subject><subject>Carotid sinus</subject><subject>Carotid Sinus - drug effects</subject><subject>Carotid Sinus - metabolism</subject><subject>Carotid sinus baroreflex</subject><subject>Clinical trials</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Imidazoles - administration &amp; dosage</subject><subject>Imidazoles - pharmacology</subject><subject>Imidazoline</subject><subject>Imidazoline agonist</subject><subject>Imidazoline receptors</subject><subject>Infusions, Intravenous</subject><subject>Injections, Intravenous</subject><subject>Intravenous administration</subject><subject>Male</subject><subject>Mercury</subject><subject>Moxonidine</subject><subject>Open-loop systems analysis</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors</subject><subject>Receptors (physiology)</subject><subject>Reflexes</subject><subject>Rodents</subject><subject>Selectivity</subject><subject>Sinus</subject><subject>Sympathetic nerve activity</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Sympathetic Nervous System - metabolism</subject><subject>Vasoconstriction - drug effects</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc-OFCEQxonRuOPqA3gxJF689AjdDQ3xZDbrn2QTPeiZ0FDtMumGFujJ7jv40NZkVg8ePJHi-9UHVR8hLznbc8bl28N-nsq-ZXzYM71nnXpEdlwNumGy44_JjrG2b7qWiQvyrJQDY0yIoXtKLlqlZa-42JFfXyGH9RaynekRctkKdRDrqYRpAldpmmg4XRwhJlSXdJdi8CECTZFmW6mzOdXgaQkR9RGrDNMMd80CPtgKqNwvq623UIOjNld8Ee3XDKVsGWiGH9tsa0jxOXky2bnAi4fzknz_cP3t6lNz8-Xj56v3N43r-6E2ox4cE62H3otx8D1IPUjLxMRG3_LODlIrrhV4xzrJnNUdFyO3AALU0DnfXZI3Z981p58blGqWUBzMs42AMxquezFwzVuN6Ot_0EPacsTfISWlElJxhRQ_Uy6nUnB8s-aw2HxvODOnqMzBYFTmFJVh2mBU2PPqwXkbcVN_O_5kg8C7MwC4imOAbIoLEB1uNWMwxqfwH_vfwoCoGw</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Kawada, Toru</creator><creator>Shimizu, Shuji</creator><creator>Yamamoto, Hiromi</creator><creator>Miyamoto, Tadayoshi</creator><creator>Shishido, Toshiaki</creator><creator>Sugimachi, Masaru</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4429-1802</orcidid></search><sort><creationdate>20171201</creationdate><title>Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation</title><author>Kawada, Toru ; Shimizu, Shuji ; Yamamoto, Hiromi ; Miyamoto, Tadayoshi ; Shishido, Toshiaki ; Sugimachi, Masaru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adrenergic receptors</topic><topic>Animals</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Antihypertensives</topic><topic>Arterial Pressure - drug effects</topic><topic>Baroreceptors</topic><topic>Baroreflex - drug effects</topic><topic>Blood pressure</topic><topic>Carotid sinus</topic><topic>Carotid Sinus - drug effects</topic><topic>Carotid Sinus - metabolism</topic><topic>Carotid sinus baroreflex</topic><topic>Clinical trials</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Imidazoles - administration &amp; dosage</topic><topic>Imidazoles - pharmacology</topic><topic>Imidazoline</topic><topic>Imidazoline agonist</topic><topic>Imidazoline receptors</topic><topic>Infusions, Intravenous</topic><topic>Injections, Intravenous</topic><topic>Intravenous administration</topic><topic>Male</topic><topic>Mercury</topic><topic>Moxonidine</topic><topic>Open-loop systems analysis</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors</topic><topic>Receptors (physiology)</topic><topic>Reflexes</topic><topic>Rodents</topic><topic>Selectivity</topic><topic>Sinus</topic><topic>Sympathetic nerve activity</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Sympathetic Nervous System - metabolism</topic><topic>Vasoconstriction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawada, Toru</creatorcontrib><creatorcontrib>Shimizu, Shuji</creatorcontrib><creatorcontrib>Yamamoto, Hiromi</creatorcontrib><creatorcontrib>Miyamoto, Tadayoshi</creatorcontrib><creatorcontrib>Shishido, Toshiaki</creatorcontrib><creatorcontrib>Sugimachi, Masaru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawada, Toru</au><au>Shimizu, Shuji</au><au>Yamamoto, Hiromi</au><au>Miyamoto, Tadayoshi</au><au>Shishido, Toshiaki</au><au>Sugimachi, Masaru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>190</volume><spage>103</spage><epage>109</epage><pages>103-109</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation separately from its central effect. In eight anesthetized Wistar rats, changes in efferent sympathetic nerve activity (SNA) and AP in response to a carotid sinus pressure input were compared before and during an intravenous administration of moxonidine (100μgkg−1 bolus followed by a continuous infusion at 200μg·kg−1·h−1). Moxonidine significantly narrowed the range of the AP response (55.3±5.8 to 39.1±6.1mmHg, P&lt;0.05) without changing the minimum AP (77.2±6.4 to 80.7±5.1mmHg, not significant). In the neural arc, moxonidine reduced the minimum SNA (56.6±5.9 to 29.7±6.2%, P&lt;0.05) without affecting the range of the SNA response (45.3±5.5 to 40.2±5.0%, not significant). In the peripheral arc, moxonidine increased the intercept (3.0±8.5 to 51.1±7.2mmHg, P&lt;0.01) and reduced the slope (1.28±0.06 to 0.92±0.15mmHg/%, P&lt;0.05). Moxonidine increased AP at any given SNA, suggesting that the peripheral vasoconstrictive effect is stronger than generally recognized. The peripheral vasoconstrictive effect of moxonidine may partly offset the vasodilatory effect attained by centrally-mediated sympathoinhibition. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>28964815</pmid><doi>10.1016/j.lfs.2017.09.038</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-4429-1802</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2017-12, Vol.190, p.103-109
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_1945719129
source ScienceDirect Journals
subjects Adrenergic receptors
Animals
Antihypertensive Agents - pharmacology
Antihypertensives
Arterial Pressure - drug effects
Baroreceptors
Baroreflex - drug effects
Blood pressure
Carotid sinus
Carotid Sinus - drug effects
Carotid Sinus - metabolism
Carotid sinus baroreflex
Clinical trials
Drug delivery systems
Drugs
Imidazoles - administration & dosage
Imidazoles - pharmacology
Imidazoline
Imidazoline agonist
Imidazoline receptors
Infusions, Intravenous
Injections, Intravenous
Intravenous administration
Male
Mercury
Moxonidine
Open-loop systems analysis
Rats
Rats, Wistar
Receptors
Receptors (physiology)
Reflexes
Rodents
Selectivity
Sinus
Sympathetic nerve activity
Sympathetic Nervous System - drug effects
Sympathetic Nervous System - metabolism
Vasoconstriction - drug effects
title Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A35%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peripheral%20versus%20central%20effect%20of%20intravenous%20moxonidine%20on%20rat%20carotid%20sinus%20baroreflex-mediated%20sympathetic%20arterial%20pressure%20regulation&rft.jtitle=Life%20sciences%20(1973)&rft.au=Kawada,%20Toru&rft.date=2017-12-01&rft.volume=190&rft.spage=103&rft.epage=109&rft.pages=103-109&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2017.09.038&rft_dat=%3Cproquest_cross%3E1945719129%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1966856818&rft_id=info:pmid/28964815&rfr_iscdi=true